Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

In a relatively short time, RFK Jr. has forced America to begin to recognize that the food choices they make have significant ...

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 21.9% year on year to $17.76 billion. On the other hand, the company ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

Cardinal's pharmaceutical and specialty solutions segment distributes branded, generic, and specialty drugs and over-the-counter healthcare and consumer products. Cardinal plays a central role in the ...

Pharma has much to gain from leveraging components of a virtual business model, especially as an innovative ... He has significant industry experience in healthcare compliance, regulatory affairs ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them. The opioid crisis in the United States continues to cause chaos and ...

Staying true to the open spirit, DeepSeek's R1 model, critically, has been fully open-sourced, having obtained an MIT license — the industry standard for software licensing. Together ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--YARAL Pharma Inc. (YARAL Pharma), the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano ...